First Time Loading...

SpringWorks Therapeutics Inc
NASDAQ:SWTX

Watchlist Manager
SpringWorks Therapeutics Inc Logo
SpringWorks Therapeutics Inc
NASDAQ:SWTX
Watchlist
Price: 45.53 USD 3.01% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

SWTX Price Targets Summary
SpringWorks Therapeutics Inc

Wall Street analysts forecast SWTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SWTX is 68.09 USD with a low forecast of 58.58 USD and a high forecast of 84 USD.

SWTX Lowest Forecast
Wall Street Target
58.58 USD
29% Upside
SWTX Average Forecast
Wall Street Target
68.09 USD
50% Upside
SWTX Highest Forecast
Wall Street Target
84 USD
84% Upside
Lowest
Price Target
58.58 USD
29% Upside
Average
Price Target
68.09 USD
50% Upside
Highest
Price Target
84 USD
84% Upside
SpringWorks Therapeutics Inc Competitors:
Price Targets
301047
Sino Biological Inc
47% Upside
VRTX
Vertex Pharmaceuticals Inc
20% Upside
HARP
Harpoon Therapeutics Inc
8% Upside
I
IVVD
Invivyd Inc
345% Upside
301047
Sino Biological Inc
47% Upside
VRTX
Vertex Pharmaceuticals Inc
20% Upside
HARP
Harpoon Therapeutics Inc
8% Upside
I
IVVD
Invivyd Inc
345% Upside
KRRO
Korro Bio Inc
111% Upside
BPMC
Blueprint Medicines Corp
7% Upside
PYC
PYC Therapeutics Ltd
278% Upside
GNTA
Genenta Science SPA
806% Upside

Revenue
Forecast

Revenue Estimate
SpringWorks Therapeutics Inc

The compound annual growth rate of SpringWorks Therapeutics Inc's revenue for the next 3 years is 343%.

N/A
Past Growth
343%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
SpringWorks Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
SpringWorks Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
What are analyst estimates?

See Also

Summary
SWTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
SWTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SWTX stock valuation using valuation multiples.
Wall Street Estimates
SWTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SWTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SWTX's stock price target?
Price Target
68.09 USD

According to Wall Street analysts, the average 1-year price target for SWTX is 68.09 USD with a low forecast of 58.58 USD and a high forecast of 84 USD.

What is SpringWorks Therapeutics Inc's Revenue forecast?
Projected CAGR
343%

The compound annual growth rate of SpringWorks Therapeutics Inc's revenue for the next 3 years is 343%.

ALPHA SPREAD
Join more than 132,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.